Pharmaceutical

Filter

Current filters:

None

Popular Filters

6710 to 6734 of 7191 results

Bristol-Myers 1st-qtr in line with expectations, as net income jumps 12%

27-04-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) reported net income for the first quarter of 2012 of $1.1…

Bristol-Myers SquibbFinancialPharmaceutical

Ranbaxy debuts first Indian-developed malaria drug, Synriam

27-04-2012

Indian drug major Ranbaxy (AB: B) said yesterday - coinciding with World Malaria Day - that it is "opening…

Asia-PacificDaiichi SankyoMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSynriamTropical diseases

Cancer drugs shortages persist in Poland

26-04-2012

In Poland, the recent procurement problems of cancer drugs is far from solved, writes Sebastian Gensior…

EuropeGenericsHealthcareNovartisOncologyPharmaceuticalPricingSandoz

US FDA again delays action on Takeda's alogliptin diabetes drug

26-04-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says it has received a complete response…

ActosalogliptinDiabetesNorth AmericaPharmaceuticalRegulationTakeda Pharmaceuticals

Vast market for glaucoma pharmaceuticals, as 50% of patients remain untreated, finds F&S

26-04-2012

Glaucoma is the second leading cause of blindness in the USA, presenting the glaucoma pharmaceuticals…

Markets & MarketingNorth AmericaOphthalmicsPharmaceutical

GlaxoSmithKline net profits fall, but firm upbeat as sales grow

26-04-2012

Shares of UK pharma giant GlaxoSmithKline (LSE: GSK) fell 3% to £14.14 yesterday, after the company…

FinancialGlaxoSmithKlinePharmaceutical

Amgen acquires Turkish drugmaker Mustafa Nevzat for $700 million

26-04-2012

Global biotech giant Amgen (Nasdaq: AMGN) has reached agreement to acquire 95.6% of Mustafa Nevzat Pharmaceuticals…

AmgenBiotechnologyMergers & AcquisitionsMustafa Nevzat PharmaPharmaceutical

Bayer kicks off 2012 with 1st-qtr sales up 6.8% and profits rocketing 53.5%

26-04-2012

Germany's Bayer Group (BAYN: DE) saw its shares rise 2.3% to 54.41 in early trading this morning, after…

BayerFinancialPharmaceutical

Eli Lilly posts 1st-qtr sales and earnings down, but still beats forecasts

26-04-2012

US drug major Eli Lilly (NYSE: LLY) reported that first-quarter 2012 worldwide revenue declined 4% to…

Eli LillyFinancialPharmaceutical

ABPI chief asks: Is saving money more important than saving lives?

25-04-2012

Speaking today at the annual meeting of the Association of the British Pharmaceutical Industry (ABPI),…

EuropeHealthcarePharmaceuticalPricing

European austerity measures lead change in generic drug pricing

25-04-2012

Generic drugs are expected to help countries cope with health care cuts brought about by strict austerity…

EuropeGenericsHealthcarePharmaceuticalPricing

Focus on the high cost of diabetes at OECD meeting

25-04-2012

Across OECD countries some 83 million people suffer from diabetes and, on current trends, that will rise…

DiabetesHealthcarePharmaceuticalPricing

First Cushing's drug, Novartis' Signifor, approved in the EU

25-04-2012

The European Commission has approved Swiss drug major Novartis' (NOVN: VX) Signifor (pasireotide) for…

EuropeNovartisOncologyPharmaceuticalRare diseasesRegulationSignifor

Boehringer Ingelheim says it is on growth path, as 2011 sales rise 6.2%

25-04-2012

German family-owned drug major Boehringer Ingelheim yesterday announced its financial results for full-year…

Boehringer IngelheimFinancialPharmaceutical

FDA extends review of Ironwood and Forest's linaclotide to September

24-04-2012

The US Food and Drug Administration has told USA-based drugmakers Ironwood Pharmaceuticals (Nasdaq: IRWD)…

Forest LaboratoriesGastro-intestinalsIronwood PharmaceuticalslinaclotideNorth AmericaPharmaceuticalRegulation

Australian CPI rise in pharmaceutical prices explained

24-04-2012

The pace of Australia's headline Consumer Price Index (CPI) inflation rose just slightly in the March…

Asia-PacificPharmaceuticalPricing

Merck KGaA to rationalize operations in Switzerland

24-04-2012

German drug major Merck KGaA (MRK: DE) has announced efficiency measures it plans to take related to…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalResearch

Canada's drug review process needs enhancements, says diabetes charity

24-04-2012

According to a new report by the charity the Canadian Diabetes Association, despite improvements to Canada's…

North AmericaPharmaceuticalRegulation

Novartis posts sharp drop in 1st-qtr profit; challenges UK off-label Avastin use

24-04-2012

Swiss drug major Novartis (NOVN: VX) has reported a sharp fall in first-quarter 2012 profits, due in…

AvastinEuropeFinancialGenericsLegalLucentisNovartisOphthalmicsPharmaceutical

Biota and Nabi announce proposed merger

24-04-2012

Australian firm Biota Holdings (ASX: BTA) and USA-based Nabi Biopharmaceuticals (Nasdaq: NABI) yesterday…

Biota HoldingsBiota PharmaceuticalsBiotechnologyMergers & AcquisitionsNabi BiopharmaceuticalsPharmaceutical

6710 to 6734 of 7191 results

Back to top